Thorsten Klampfl

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl, Heinz Gisslinger, Ashot S. Harutyunyan et al. · New England Journal of Medicine · 2013 · 2K citations · Full text

Medicine, Genetics, Hematology +14

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Elisa Rumi, Daniela Pietra, Virginia Valeria Ferretti et al. · Blood · 2013 · 585 citations · Full text

Medicine, Genetics, Hematology +13

The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

Georg E. Winter, Branka Radic-Sarikas, Cristina Mayor‐Ruiz et al. · Nature Chemical Biology · 2014 · 184 citations

Life Sciences, Genetics, Molecular Biology +13

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

Thorsten Klampfl, Ashot S. Harutyunyan, Tiina Berg et al. · Blood · 2011 · 178 citations · Full text

Medicine, Genetics, Molecular Genetics +14

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms

Roland Jäger, Heinz Gisslinger, Francesco Passamonti et al. · Leukemia · 2010 · 134 citations · Full text

Medicine, Genetics, Molecular Genetics +11